LeadR Profile

{{ forename }} {{ lastname }}{{ getFilteredTitles("first") }}{{ getFilteredTitles("second") }} Osaka Metropolitan University Hospital Japan
947 ScienceLeadR Reputation 947
Network Map

Rheumatology

Subspecialties: Immunology - Internal Medicine - Biochemistry

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Short Biography

Trained under Prof. Shimon Sakaguchi, the 2025 Nobel Laureate recognized for the discovery of regulatory T cells, Prof. Motomu Hashimoto has advanced pioneering research bridging basic and clinical immunology. His work using a monogenic autoimmune mouse model has elucidated mechanisms through which genetic and environmental factors determine disease phenotypes—including rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthritis. In clinical research, Prof. Hashimoto established the ANSWER cohort, Japan’s largest rheumatoid arthritis registry, generating real-world evidence that informs the optimal use of molecular targeted therapies. His major contributions integrating bench and bedside research were honored with the 2025 Japan College of Rheumatology Scientific Award.


Key Research Achievements

Basic research

1. Yoshida T, Hashimoto M. et al. Arthritis Res Ther. 2025 ;27(1):143

2. Katsushima M, Hashimoto M. et al. Rheumatology (Oxford). 2025 ;64(5):3104-3115

3. Shirakashi M, Hashimoto M. et al. Arthritis Rheumatol. 2022 ;74(4):641-653.

4. Tabuchi Y, Hashimoto M. et al. Arthritis Res Ther. 2022 ;24(1):176.

5. Matsuo T, Hashimoto M. et al. J Immunol. 2019;202(11):3161-3172.

6. Hirota K, Hashimoto M, et al. Immunity. 2018: S1074-7613(18)30146-8.

7. Ito Y, Hashimoto M, et al. Science. 2014;346(6207):363-8.

8. Hashimoto M, et al. J Exp Med. 2010;207(6):1135-43.


Clinical Research

1. Torii M, Hashimoto M. et al. Arthritis Res Ther. 2026;28(1):66.

2. Smolen JS, Hashimoto M, Taylor PC, et al. RMD Open. 2026 ;12(1):e006094

3. Fujisawa Y, Hashimoto M. et al. Rheumatology (Oxford). 2026 ;65(2):keaf602.

4. Watanabe R, Hashimoto M. et al. Rheumatology (Oxford). 2024 ;63(9):2418-2426.

5. Nakayama Y, Hashimoto M. et al. Rheumatology (Oxford). 2024; 63(2):349-357.

6. Iwasaki T, Hashimoto M. et al. Front Immunol. 2022 6;13:901437.

7. Nakayama Y, Hashimoto M. et al. Rheumatol Int. 2022 ;42(7):1227-1234.

8. Hashimoto M, et al. Arthritis Res Ther. 2018;20(1):165. .

9. Hashimoto M, et al. PLoS One. 2015;10:e0122121.


Organizations

Source: Pubmed

{{ exp.name }}

Publications Synthesis

Source: Pubmed

Number : 315

Citations

Citations: 9 239 1st author: 12 Last author: 59 Unique author: 3

Main journals

Mod Rheumatol 33
Rheumatology (Oxford) 26
PLoS One 21
Arthritis Res Ther 20
Front Immunol 11

Best Journals

Nat Genet 1
Nature 1
Science 1

Breakdown by type

Clinical Studies 6

Source: ClinicalTrials

Synthesis

Principal Investigator: 1

By phase:

Phase 3 3
Phase 2 2
Phase 4 1

By status:

Completed 3
Active not recruiting 2
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Immune System Diseases 3
Skin and Connective Tissue Diseases 3
Musculoskeletal Diseases 2

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials